(Q50433151)

13 March 2018

title

Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis. (English)

1 reference

13 March 2018

0 references

1 reference

1

1 reference

13 March 2018

Tuula Tyry

series ordinal

3

object named as

Tuula Tyry

1 reference

13 March 2018

Gary R. Cutter

series ordinal

2

object named as

Gary Cutter

0 references

publication date

15 August 2011

1 reference

13 March 2018

Multiple Sclerosis Journal

published in

1 reference

13 March 2018

volume

17

1 reference

13 March 2018

issue

12

1 reference

13 March 2018

page(s)

1464-1471

1 reference

13 March 2018

Efferent visual dysfunction from multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Is optic neuritis more benign than other first attacks in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

The neuro-ophthalmology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Important Causes of Visual Impairment in the World Today

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Validity of performance scales for disability assessment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Economic impact of visual impairment and blindness in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Ischemic optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Normal human aging: factors contributing to cerebral atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Stroke risk factors and loss of high cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Clinical practice. Retinal-vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Response rates to mail surveys published in medical journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Validity of self-reported diagnoses leading to hospitalization: a comparison of self-reports with hospital records in a prospective study of American adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Prevalence of cataract and pseudophakia/aphakia among adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Prevalence of glaucoma. The Beaver Dam Eye Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Comorbidity, socioeconomic status and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

Population-based assessment of adverse events associated with long-term glucocorticoid use

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414041

21 January 2018

Identifiers

DOI

10.1177/1352458511414041

1 reference

13 March 2018

1 reference

13 March 2018